SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2026)

SOPHiA GENETICS has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$2.5 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 58.89% year-over-year to -$2.5 million; the TTM figure through Jun 2026 stood at -$11.1 million (down 112.9% YoY), while the FY2025 annual figure was -$8.7 million, down 82.33% from the prior year.
• Cash from Investing Activities came in at -$2.5 million for Q2 2026 at SOPHiA GENETICS, up from -$2.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $18.0 million in Q2 2022 to a low of -$3.5 million in Q4 2025.
• Average Cash from Investing Activities over 5 years is $2.0 million, with a median of -$1.2 million recorded in 2024.
• Year-over-year, Cash from Investing Activities surged 1044.1% in 2022 and slumped 178.02% in 2025.
• Over 5 years, Cash from Investing Activities stood at $12.1 million in 2022, then plunged by 80.18% to $2.4 million in 2023, then slumped by 152.37% to -$1.3 million in 2024, then tumbled by 178.02% to -$3.5 million in 2025, then advanced by 29.6% to -$2.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.5 million in Q2 2026, -$2.6 million in Q1 2026, and -$3.5 million in Q4 2025.